Venoactive medications and the place of MPFF at a dose of 500 mg in recent guidelines on the management of chronic venous disease
Andrew NICOLAIDES Vascular Screening Diagnostic Centre, Nicosia, Cyprus ABSTRACT Because the venous system is in many respects more complex than the arterial system, because chronic venous disease (CVD) is common in Western populations, and because both specialists and general practitioners have to deal with this disease, there is a need for practical support regarding CVD management in daily practice. This article summarizes the most recent guidelines regarding the place of venoactive drugs (VADs) such as MPFF at a dose of 500 mg in the management of this disease. In addition, it makes suggestions regarding expected improvements in future guideline documents….
